300 related articles for article (PubMed ID: 1712712)
21. Comparison of loop diuretics in patients with chronic renal insufficiency.
Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
[TBL] [Abstract][Full Text] [Related]
22. Effect of bumetanide and furosemide on the thick ascending limb of Henle's loop of rabbits and rats perfused in vitro.
Imai M
Eur J Pharmacol; 1977 Feb; 41(4):409-16. PubMed ID: 844482
[TBL] [Abstract][Full Text] [Related]
23. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.
Ju M; Scott-Ward TS; Liu J; Khuituan P; Li H; Cai Z; Husbands SM; Sheppard DN
Br J Pharmacol; 2014 Jan; 171(1):265-78. PubMed ID: 24117047
[TBL] [Abstract][Full Text] [Related]
24. Effect of furosemide, bumetanide and piretanide on the sensor of the tubuloglomerular feedback mechanism.
Brunkhorst R; Müller-Ott K; Gutsche HU; Niedermayer W
Proc Eur Dial Transplant Assoc; 1978; 15():613-6. PubMed ID: 740700
[No Abstract] [Full Text] [Related]
25. Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats.
Unwin RJ; Walter SJ; Giebisch G; Capasso G; Shirley DG
Clin Sci (Lond); 2000 Apr; 98(4):481-8. PubMed ID: 10731484
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma.
Yeo CT; O'Connor BJ; Chen-Worsdell M; Barnes PJ; Chung KF
Eur Respir J; 1992 Nov; 5(10):1184-8. PubMed ID: 1486963
[TBL] [Abstract][Full Text] [Related]
27. Loop-diuretic inhibition of adrenaline-stimulated Cl- secretion in a cultured epithelium of renal origin (MDCK).
Brown CD; Rugg EL; Simmons NL
Q J Exp Physiol; 1986 Apr; 71(2):183-93. PubMed ID: 3714958
[TBL] [Abstract][Full Text] [Related]
28. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Clissold SP; Brogden RN
Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
[TBL] [Abstract][Full Text] [Related]
29. The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.
Knauf H; Spahn H; Mutschler E
Drugs; 1991; 41 Suppl 3():23-34. PubMed ID: 1712713
[TBL] [Abstract][Full Text] [Related]
30. Effects of torasemide on renal haemodynamics and function in anaesthetized dogs.
Uchida T; Hayashi K; Suzuki Y; Matsumura Y
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):497-504. PubMed ID: 1914250
[TBL] [Abstract][Full Text] [Related]
31. [Update: prolonged-release torasemide].
Acuña C
Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
[TBL] [Abstract][Full Text] [Related]
32. The clinical pharmacology of loop diuretics in the pediatric patient.
Eades SK; Christensen ML
Pediatr Nephrol; 1998 Sep; 12(7):603-16. PubMed ID: 9761364
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of bumetanide.
Cohen M
J Clin Pharmacol; 1981; 21(11):537-42. PubMed ID: 7338563
[TBL] [Abstract][Full Text] [Related]
34. Na+,2Cl-,K+ cotransport system as a marker of antihypertensive activity of new torasemide derivatives.
Masereel B; Ferrari P; Ferrandi M; Pirotte B; Schynts M; Parenti P; Delarge J
Eur J Pharmacol; 1992 Sep; 219(3):385-94. PubMed ID: 1425967
[TBL] [Abstract][Full Text] [Related]
35. [Loop-diuretics anno 1992. Mechanisms of effect and current therapeutic principles].
Berg KJ
Tidsskr Nor Laegeforen; 1992 Feb; 112(5):656-8. PubMed ID: 1557735
[TBL] [Abstract][Full Text] [Related]
36. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
Delarge J
Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
[TBL] [Abstract][Full Text] [Related]
37. Effect of diuretics on the tubuloglomerular feedback response.
Gutsche HU; Brunkhorst R; Müller-Ott K; Franke H; Niedermayer W
Can J Physiol Pharmacol; 1984 Apr; 62(4):412-7. PubMed ID: 6733586
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological activity of a series of torasemide derivatives, potent blockers of the Na+ 2Cl- K+ co-transporter: in-vitro study.
Masereel B; Lohrmann E; Schynts M; Pirotte B; Greger R; Delarge J
J Pharm Pharmacol; 1992 Jul; 44(7):589-93. PubMed ID: 1357140
[TBL] [Abstract][Full Text] [Related]
39. Variance comparison as a tool in clinical pharmacology: an example with two loop diuretics.
Imbs JL; Schmidt M; Spriet A; Schwartz J
Eur J Clin Pharmacol; 1982; 23(3):221-4. PubMed ID: 6756934
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
